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Acute hemodialysis of infants weighing less than five kilograms. The
records of 33 infants weighing 5 kg or less who received acute
hemodialysis treatment at Children's Hospital between 1980 and 1991
were reviewed. Dialysis was initiated to treat hyperammonemia (8),
primary renal or renovascular disease (7), and acute renal failure (18).
The infants weighed 2.2 to 4.0 kg at birth and 27% were born
prematurely. The infants were 2 to 120 days of age (median 10 days) and
weighed 2.2 to 5.0 kg (median 3.5 kg) at the initiation of hemodialysis.
Hemodialysis access was achieved via double-lumen 7 French catheters
in 49% of the infants, the ECMO circuit in 24%, and the umbilical
vessels in 27%. Thirty-three infants underwent a total of 216 hemodi-
alysis treatments. Only nine treatments were discontinued prematurely:
six for intractable hypotension and three for technical problems.
Fifty-two percent (17 of 33) of the infants survived through the end of
the hemodialysis treatment course. The survival rates for the infants
with hyperammonemia (75%) and primary renal disease (71%) were
better than those for infants with acute renal failure (33%). The
survivors did not differ from those who died with respect to birthweight,
weight when hemodialysis was initiated, or the number of hemodialysis
treatments administered. We conclude that infants weighing less than
5 kg can be treated successfully with hemodialysis. Patient survival is
related to underlying medical problems, not to complications of hemo-
dialysis.
Although hemodialysis of children was described as early as
1955 [1], the utilization of this treatment for infants has been
limited largely due to technical problems such as difficult
vascular access and the inability to precisely control ultrafiltra-
tion. These problems have been overcome by the development
of small dual-lumen vascular catheters and ultrafiltration-
control dialysis machines. Despite these advances and descrip-
tions of successful treatment methods [2—6], hemodialysis of
small infants is still viewed by some as inappropriate, techni-
cally unmanageable, or frankly dangerous. As a result, many
centers prefer peritoneal dialysis or continuous ai-teriovenous
hemofiltration for acute management of infants [7—9]. These
other modalities, however, are not optimal for the clearance of
small solutes, including ammonia, or for the rapid removal of
fluid [10—12]. Hemodialysis has clear advantages in these cases.
Furthermore, in certain clinical settings such as fungal perito-
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nitis or recent abdominal surgery, peritoneal dialysis may not
be appropriate.
Thirty-four infants weighing 5 kg or less were treated with
acute hemodialysis at Children's Hospital between 1980 and
1991. We reviewed the hemodialysis treatment courses of these
infants in order to determine the extent and frequency of
complications encountered and to determine the survival rate of
small infants receiving acute hemodialysis.
Methods
Characteristics of Infants
Complete data were available on the acute hemodialysis
courses of 33 infants. Complete medical records were unavail-
able for one additional infant. The underlying problems neces-
sitating dialysis included hyperammonemia (8), primary renal or
renovascular disease (7), and acute renal failure (18). The
metabolic disorders responsible for the hyperammonemia in-
cluded methylmalonic acidemia, ornithine transcarbamylase
deficiency, carbamyl phosphate synthetase deficiency, and
argininosuccinic acid synthetase deficiency. The intrinsic renal
or renovascular disorders included renal dysplasia (3), mesan-
gial sclerosis (2), autosomal recessive polycystic kidney disease
(1), and bilateral renal vein thrombosis (1). Acute renal failure
was associated with extracorporeal membrane oxygenation
(ECMO) (11), surgery (3), or medical conditions with severe
hemodynamic compromise (4): Kasabach-Merritt syndrome,
Rh incompatibility, prolonged hypoxia, and non-immune hy-
drops.
Characteristics of the infants in each of the three groups are
shown in Table 1. The median birthweight of all infants was 3.1
kg (2.2 to 4.0 kg). The median gestational age was 39 weeks (32
to 43 weeks). Overall, 27% of the infants were preterm, that is,
<37 weeks gestational age. More infants were treated with
hemodialysis from 1989 to 1991 (27) than prior to 1989 (6). The
primary indications for acute dialysis were hyperkalemia,
azotemia, severe fluid overload, contrast agent removal in the
setting of renal insufficiency, hyperammonemia, and severe
acidosis. The median laboratory values in these patients in-
cluded: serum potassium 6.9 mEq/liter (6.5 to 7.7), serum BUN
112 mgldl (91 to 174), and blood ammonia 1858 mg/dl (1178 to
2500). Most of the infants had several concurrent indications for
dialysis. Two patients undergoing chronic peritoneal dialysis
required short-term hemodialysis treatment during episodes of
hypercalcemia (serum calcium 18.9 mg!dl) and fungal peritoni-
tis.
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Table 1. Description of all infants dialyzed
Etiologic group
Number of
patients
Birthweight Gestational Preterm
kg age weeks infants
Age at
initiation
day?
Weight at
Initiation
kga
Hyperammoneinia 8 2.3—4.0 37—43 0 4,5
(3—5.0)
3.2
(2.2-4.1)
Renal 7 2.2—3.7 32—40 43% 48
(17—120)
3.8
(2.8—4.3)
Acute renal failure 18 2.2—3.7 32—43 33% 10.5
(2—91)
3.4
(2.5—5.0)
a median, (range)
Table 2. Characteristics of patient hemodialysis (LID) treatment courses
Etiologic group
#HD
treatmentsa
Length of HD Hypotension
course daysa during HDb
Inotropic Rx
during HD"
Patient
survivald
Hyperammonemia 4.5
(1—7)
3 63%
(1—5)
13% 75%
Renal 12
(1—31)
18 71%
(1—42)
26% 71%
Acute renal failure 2.5
(1—19)
2.5 61%
(1—25)
50% 33%
a median, (range)b Patients (%) with hypotension during at least 1 HD treatment
"Patients (%) requiring initiation or augmentation of inotropic support during at least 1 1-ID treatmentd Survival through the end of the hemodialysis treatment course
Hemodialysis treatment techniques
Vascular access was achieved by several means. Double-
lumen seven French catheters were used to access subclavian,
femoral, or internal jugular veins in 49% of the infants. Subcla-
vian and internal jugular catheter tips were located in the
superior vena cava or the right atrium; those located in the right
atrium were generally more consistent in maintaining blood
flow rates. Single-needle technique was never employed. There
were circumstances when two single-lumen catheters were
used, but only in infants with specialized access sites, that is,
the ECMO circuit or umbilical vessels. The ECMO circuit was
utilized for 24% of the infants, and the umbilical vessels were
accessed with 5 French arterial and 8 French venous catheters
in 27% of the infants. A mixture of blood and albumin was used
to prime the dialysis circuit in order to prevent extracorporeal
circulation of greater than 10% of the infant's estimated blood
volume. The volume of the extracorporeal circuit was approx-
imately 100 cc. Blood flows were maintained between 25 and 50
ml/min. All patients were anticoagulated with heparin, and
heparin doses were determined by serial activated clotting
times. The dialyzer surface areas ranged from 0.3 to 0.6 M2. A
parallel plate dialyzer was used for one infant dialyzed in 1980.
Hollow fiber dialyzers were used for the other 32 infants. For
infants dialyzed for renal failure, dialysis treatment times
ranged from 20 to 120 minutes; for those dialyzed for hyperam-
monemia, treatment times ranged from 1-1/2 to 23 hours (me-
dian 3 hr). The infant dialyzed for 23 hours was the second in
our series of infants with hyperammonemia. We have subse-
quently changed to multiple, shorter hemodialysis treatments
for infants with markedly elevated ammonia levels. Since 1986
ultrafiltration-control machines (such as Seratronics and Fres-
enius) were used. Prior to the availability of ultrafiltration-
control machines, bed scales were used to determine the
volume ultrafiltered. Bicarbonate-based dialysate was utilized
in 31 of 33 infants. Acetate-based dialysate was used in two
infants dialyzed prior to 1985. In the setting of severe volume
overload, sequential ultrafiltration/hemodialysis was sometimes
performed.
Hypotension was initially treated with boluses of normal
saline or albumin (5% solution). Mannitol and other hyperos-
motic agents were never employed. In some cases treatment
with inotropic agents was initiated or their doses were aug-
mented.
Results
The infants were between 2 and 120 days of age (median 10
days) and weighed 2.2 to 5.0 kg (median 3.5 kg) when hemodi-
alysis was initiated (Table 1). They underwent a total of 216
hemodialysis treatments (median 4, range I to 31) over 1 to 42
days (median 4 days; Table 2). The dialysis treatments were
completed as prescribed in 207 of 216 treatments (96%). Only
nine treatments were discontinued prematurely: three as a
result of technical problems and six for intractable hypotension.
Technical problems, such as transiently inadequate blood
flow through the dialysis catheter or dialyzer clotting, occurred
in one or more of the hemodialysis treatments of 15 (45%) of the
infants. However, only three treatments were discontinued
prematurely as a result of dialyzer clotting, inability to maintain
adequate blood flow, or marked oozing of blood from an
umbilical catheter exit site. There were only three catheter-
related infections during the total of 268 patient-days with
catheters in place. No infection necessitated the termination of
hemodialysis. Although many of the infants were receiving
broad-spectrum antibiotics during their dialysis treatment
courses, antibiotics were not specifically given for prophylaxis
following catheter insertion.
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Fig. 1. Percentages of infants with intradialytic complications. The
bars indicate the percentage of infants in each of the etiologic groups
(hyperammonemia; acute renal failure; renal: intrinsic renal or renovas-
cular disease) with hypotension (0) during one or more hemodialysis
treatments; the percentage of infants requiring initiation or augmenta-
tion of inotropic support (D); and the percentage of infants having
seizures (El) during hemodialysis.
Sixty-four percent of the infants had hypotensive episodes
during one or more of their hemodialysis treatments (Fig. 1).
The incidence of hypotension and the number of times that
saline or albumin was administered were similar among the
infants with hyperammonemia, renal disease, and acute renal
failure. In contrast, the percentage of infants requiring the
initiation or augmentation of inotropic support during treat-
ments differed among the etiologic groups: hyperammonemia
(13%), renal and renovascular disease (26%), and acute renal
failure (50%) (Fig. 1). The varying requirements for inotropic
support were associated with the predialysis hemodynamic
status of the infants. The infants with acute renal failure had
multi-organ compromise and more frequently required inotro-
pic support prior to dialysis.
Seizure activity was noted in six of the 33 infants during
hemodialysis (Fig. 1). Five of these infants had seizures prior to
their first hemodialysis treatment. In addition, three of the six
infants were being dialyzed for hyperammonemia, a condition
known to cause profound changes in neurological status [13].
The remaining three infants had acute renal failure. No infants
with primary renal disease had seizures. Thus, seizure activity
during dialysis was infrequent and could be attributed in at least
five of six infants to the underlying medical condition and not to
the dialysis procedure itself.
Seventeen of the thirty-three infants (52%) survived through
the end of the hemodialysis treatment course. Overall, term
infants had better survival (14 of 24, 58%) than preterm infants
(3 of 9, 33%). The survival of infants with renal or renovascular
disease (5 of 7, 71%) was comparable to that of infants with
hyperammonemia (6 of 8, 75%; Table 2). In contrast, the
survival of infants with acute renal failure was only 33% (6 of
18). No deaths were attributable to renal failure or complica-
tions of the hemodialysis treatments. Individual patient survival
could not be predicted on the basis of gestational age, birth-
weight, weight or age when hemodialysis was initiated, or the
number of treatments received.
The amount of residual renal function in those who survived
the acute hemodialysis course varied. There was full recovery
of renal function or no initial compromise in the six surviving
infants with hyperammonemia. Four of the five infants with
primary renal disease required chronic peritoneal dialysis,
while one had residual renal insufficiency. Four of the six
infants surviving acute renal failure had full recovery of renal
function and two had continuing renal insufficiency.
Discussion
The present study of small infants treated with acute hemo-
dialysis is the largest series reported to date. The 33 infants
described in this report experienced remarkably few complica-
tions during their hemodialysis treatments. In spite of concerns
about the hemodynamic instability of small infants and the
complications that might arise during treatments, only nine of
216 treatments were discontinued prematurely for dialysis-
related complications. In all but six of the treatments, hypoten-
sion could be adequately managed with boluses of albumin or
normal saline or the use of inotropic agents. It is particularly
remarkable that only 64% of these critically ill infants had
hypotensive episodes during hemodialysis in view of the fact
that 30 to 50% of chronic adult hemodialysis patients regularly
experience hypotension [14].
Overall, patient survival was better for those infants with
hyperammonemia and primary renal disorders than for those
with acute renal failure. The fact that the survival rate varied
with the underlying reason for dialysis is not unexpected. The
infants with acute renal failure had severe multi-organ compro-
mise. The 33% survival rate in this group is comparable to the
17% survival reported for infants and children with acute renal
failure treated with hemodialysis in one center [15] and to the
39% survival rate in neonates receiving acute peritoneal dialysis
in another center [8]. The mortality in both of these studies, as
in the present one, was attributable to the severity of the
underlying medical disorders and not to the compromise in
renal function itself or to complications of the dialysis treat-
ments. In contrast to the infants with acute renal failure, those
with primary renal or renovascular disease had a survival rate
of 71%. Hodson, Kjellstrand and Mauer have shown a 90%
survival rate for children with primary nephrologic disorders
receiving acute hemodialysis; however, their population in-
cluded only two patients less than one year of age [15].
The survival rate of infants with renal disease in the present
study should be encouraging for pediatricians, intensivists, and
pediatric nephrologists who care for infants with severe renal
disease. In view of this favorable survival rate, hemodialysis
should be viewed as a reasonable, and sometimes the preferred,
treatment option for the initial management of small infants
with chronic renal failure. Although continuous replacement
therapy (such as CAVH and CVVH) may be preferable in some
instances in which infants are hypotensive, hemodialysis offers
better and more controlled small solute clearance, including
ammonia, and the ability to remove fluid rapidly. Hemodialysis
may also be a valuable alternative when acute peritoneal
dialysis is inappropriate. In association with the improving
status of chronic peritoneal dialysis and transplantation in
young children [16—19], acute hemodialysis can be considered
an integral part of a long-term treatment plan for small infants
with chronic renal failure.
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